The co-management of tuberculosis-diabetes co-morbidities in Indonesia under the National Tuberculosis Control Program: results from a cross-sectional study from 2017 to 2019

Table 1 Characteristics of TB patients and TB-DM patients in East and South Jakarta

	TB patients without DM diagnosis		TB-DM patients		P-value
	N	%	N	%
Total	23,652	/	2796	/	NA
Region
East Jakarta	15,332	64.8	1826	65.3	0.615
South Jakarta	8320	35.2	970	34.7
Year
2017* (Q4)	1746	7.4	133	4.8	< 0.001
2018	10,298	43.5	1143	40.9
2019	11,688	49.1	1520	54.4
Gender
female	10,022	42.2	1147	41.0	0.175
male	13,630	57.8	1649	59.0
Age
15–44	14,380	60.8	589	21.1	< 0.001
> =45	9272	39.2	2207	78.9
Patients’ origin (by ID card)
in this region	19,648	83.1	2445	87.4	< 0.001
outside this region	4004	16.9	351	12.6
TB treatment status
received standard treatment	20,264	85.7	2613	93.5	< 0.001
non-standard	3388	14.3	183	6.5
Diagnosis Type
bacteriologically confirmed	13,176	55.7	2104	75.3	< 0.001
clinically diagnosed	10,476	44.3	692	24.7
TB test taken
Acid-Fast Bacillus (AFB) smear test	12,847	48.6	1440	51.5
rapid molecular test	10,406	39.3	1593	56.9	< 0.001
culture test	453	1.7	73	2.7
no test records	2756	10.4	135	4.8
Treatment outcome
complete treatment	11,489	48.6	968	34.6	< 0.001
cured	7931	33.5	1286	46.0
default	1968	8.3	218	7.8
transfer	973	4.1	129	4.6
dead	470	2.0	75	2.7
relapse	239	1.0	70	2.5
not available data	582	2.5	50	1.8
Type of facility where patients were reported
health center at sub-district level	3385	14.3	560	20.0	< 0.001
health center at sub-sub district level	6585	27.8	926	33.1
government hospital	8818	37.1	994	35.6
private hospital	4864	20.6	316	11.3
Receive DM Treatment
metformin and others	/		2202	78.8	NA
insulin injection	/		172	6.2
no DM treatment	/		422	15.1

ISSN: 1471-2458